Psyence Biomedical Ltd.
PBM
Get informed when a big investor buys or sells
+ FollowMarket Cap$126K
Close$
$7.60
17.2% upside
Current Fair Value
17.2% upsideUndervalued by 17.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $126,001.00 |
|---|---|
| Enterprise Value | $-7,071,175.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.72 |
| Outstanding Shares | 1,481,527 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.81 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 24, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.88%▲ 14.67% |
|---|---|
| Total Invested | $1.24M▲ 115.66% |
| Investors Holding | 9▲ 7.00% |
ESG Score
No data